Key facts
- It has raised $2.8M; the latest was Later Stage VC in May 2025.
- Notable investors include Techstars, Right Side Capital Management, Kickstart (US), Arben Ventures, Lionheart Ventures — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Outro
- ·The full record, as it builds
Funding rounds
No funding rounds for Outro are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Outro
Developer of a digital health platform designed to support the safe reduction and discontinuation of prescription antidepressant medications. The company offers structured medication tapering programs, clinical guidance, and patient monitoring tools, enabling patients and healthcare providers to manage antidepressant deprescribing and reduce withdrawal-related risks.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2014
- Employees
- 10
- Website
- outro.com/
- Ownership
- Privately Held (backing)
Outro doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Outro shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Outro in its N-PORT filings yet. We sweep new filings monthly.